| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.9M | — | -16.2% |
| Cost of Revenue | $4.7M | — | +2.5% |
| Gross Profit | $9.2M | — | -23.4% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $4.9M | — | -3.9% |
| Operating Income | -$1.5M | — | -61.7% |
| Pre-tax Income | $2.0M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $32.6M | +5.4% | +62.3% |
| Accounts Receivable | $33.2M | +6.6% | +43.5% |
| Inventory | $10.1M | -11.7% | -14.0% |
| Current Assets | $81.1M | +2.4% | — |
| Total Assets | $125.0M | +0.7% | +7.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$618K | — | +48.1% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | -100.0% |
| Financing Cash Flow | $2.3M | — | +152.0% |
| Free Cash Flow | -$618K | — | +53.4% |
| +31.2% |
| Income Tax | $0 | — | -100.0% |
| Net Income | $2.0M | — | +33.3% |
| EPS (Basic) | $0.21 | — | -12.5% |
| EPS (Diluted) | -$0.08 | — | +46.7% |
| $66.0M |
| +4.6% |
| +7.7% |
| Long-term Debt | $10.4M | -4.1% | +0.2% |
| Stockholders' Equity | $23.2M | +22.2% | -22.3% |